Skip to Main Content

Paper Details

Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastases.
NPJ Breast Cancer
13
2022
BCBM, Breast cancer brain metastases, CTLA-4, HER2, HER2+, T-cell, breast cancer brain metastases, cytotoxic T-lymphocyte associated protein 4, human epidermal growth factor receptor, metastatic breast cancer, non-, patient, patients, peripheral blood, trastuzumab, tremelimumab, tumor
Author NameAffiliation
Kateri J SpinelliProvidence Cancer Institute, Earle A. Chiles Research Institute
Thomas J KaleyMemorial Sloan Kettering Cancer Center
Larry NortonMemorial Sloan Kettering Cancer Center
Larry NortonMemorial Sloan Kettering Cancer Center
  • 1 - 4

Datasets

Release 1.2